These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3491421)
1. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production. Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421 [TBL] [Abstract][Full Text] [Related]
2. The effect of short-term corticosteroid incubation on the alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Braathen LR; Hirschberg H Br J Dermatol; 1984 Sep; 111(3):295-302. PubMed ID: 6332641 [TBL] [Abstract][Full Text] [Related]
3. HLA-D/DR restriction of Langerhans cell-dependent antigen activation of T lymphocytes. The same D/DR determinants are restriction elements on monocytes and Langerhans cells. Berle EJ; Braathen LR; Thorsby E Scand J Immunol; 1982 Dec; 16(6):549-52. PubMed ID: 6186017 [TBL] [Abstract][Full Text] [Related]
4. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions. Sontheimer RD J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806 [TBL] [Abstract][Full Text] [Related]
5. Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells. Bjercke S; Elgø J; Braathen L; Thorsby E J Invest Dermatol; 1984 Oct; 83(4):286-9. PubMed ID: 6090538 [TBL] [Abstract][Full Text] [Related]
6. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Ashworth J; Booker J; Breathnach SM Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268 [TBL] [Abstract][Full Text] [Related]
7. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells. Prens EP; Benne K; van Joost T; Benner R J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638 [TBL] [Abstract][Full Text] [Related]
8. Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T-cell responses. Braathen LR; Thorsby E Br J Dermatol; 1983 Feb; 108(2):139-46. PubMed ID: 6186267 [TBL] [Abstract][Full Text] [Related]
9. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Grage-Griebenow E; Lorenzen D; Fetting R; Flad HD; Ernst M Eur J Immunol; 1993 Dec; 23(12):3126-35. PubMed ID: 7504990 [TBL] [Abstract][Full Text] [Related]
10. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes. Woo J; Propper DJ; Thomson AW Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987 [TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation. Cooper KD; Neises GR; Katz SI J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes. Bhardwaj N; Lau LL; Friedman SM; Crow MK; Steinman RM J Exp Med; 1989 Mar; 169(3):1121-36. PubMed ID: 2522495 [TBL] [Abstract][Full Text] [Related]
13. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function. Péguet-Navarro J; Dalbiez-Gauthier C; Dezutter-Dambuyant C; Schmitt D Eur J Immunol; 1993 Feb; 23(2):376-82. PubMed ID: 8436173 [TBL] [Abstract][Full Text] [Related]
14. Collaboration between human blood dendritic cells and monocytes in antigen presentation. Räsänen L; Lehto M; Hyöty H; Leinikki P APMIS; 1989 Nov; 97(11):981-6. PubMed ID: 2531600 [TBL] [Abstract][Full Text] [Related]
15. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF). Breathnach SM; Katz SI J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770 [TBL] [Abstract][Full Text] [Related]
16. Effect of UVA and PUVA on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Mørk NJ; Gaudernack G; Braathen LR Photodermatol; 1987 Apr; 4(2):66-72. PubMed ID: 3498937 [TBL] [Abstract][Full Text] [Related]
17. Accessory function of human Langerhans cells in the primary allogeneic T-cell response. Péguet-Navarro J; Dalbiez-Gauthier C; Schmitt D J Invest Dermatol; 1992 Nov; 99(5):87S-88S. PubMed ID: 1431240 [TBL] [Abstract][Full Text] [Related]
18. Accessory cell function of human alveolar macrophages in antigen-induced T lymphocyte proliferation. Ohtsuka M; Yoshizawa Y; Sato T; Yano H; Mukai R; Hasegawa S; Moore VL Int Arch Allergy Appl Immunol; 1989; 90(1):97-103. PubMed ID: 2530179 [TBL] [Abstract][Full Text] [Related]
19. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens. Walsh LJ; Seymour GJ; Powell RN J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Péguet-Navarro J; Moulon C; Caux C; Dalbiez-Gauthier C; Banchereau J; Schmitt D Eur J Immunol; 1994 Apr; 24(4):884-91. PubMed ID: 8149959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]